End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
6.2
CNY
|
+3.16%
|
|
+7.08%
|
-16.89%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
5,645
|
4,951
|
4,133
|
5,528
|
18,292
|
10,530
|
Enterprise Value (EV)
1 |
5,413
|
5,197
|
4,571
|
5,957
|
18,527
|
10,953
|
P/E ratio
|
64.5
x
|
30.8
x
|
50.6
x
|
34.4
x
|
101
x
|
51.9
x
|
Yield
|
0.68%
|
1.75%
|
1.4%
|
1.55%
|
-
|
0.45%
|
Capitalization / Revenue
|
4.67
x
|
2.74
x
|
2.48
x
|
2.76
x
|
8.83
x
|
5.26
x
|
EV / Revenue
|
4.48
x
|
2.88
x
|
2.75
x
|
2.97
x
|
8.94
x
|
5.47
x
|
EV / EBITDA
|
27.1
x
|
16.2
x
|
14.6
x
|
16.7
x
|
51.6
x
|
28.4
x
|
EV / FCF
|
-1,202
x
|
-24.7
x
|
116
x
|
33.2
x
|
81.1
x
|
-46.8
x
|
FCF Yield
|
-0.08%
|
-4.04%
|
0.86%
|
3.01%
|
1.23%
|
-2.14%
|
Price to Book
|
2.95
x
|
2.49
x
|
2.1
x
|
2.7
x
|
8.41
x
|
4.41
x
|
Nbr of stocks (in thousands)
|
963,309
|
963,309
|
963,309
|
954,686
|
954,686
|
954,686
|
Reference price
2 |
5.860
|
5.140
|
4.290
|
5.790
|
19.16
|
11.03
|
Announcement Date
|
4/19/18
|
4/19/19
|
4/27/20
|
4/26/21
|
4/28/22
|
4/25/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
1,208
|
1,806
|
1,664
|
2,003
|
2,072
|
2,001
|
EBITDA
1 |
200
|
320
|
312.3
|
356.7
|
359
|
385.3
|
EBIT
1 |
109.5
|
207.9
|
192.4
|
232.4
|
232.9
|
254.3
|
Operating Margin
|
9.07%
|
11.51%
|
11.56%
|
11.6%
|
11.24%
|
12.71%
|
Earnings before Tax (EBT)
1 |
77.65
|
205.6
|
113
|
186.2
|
218.6
|
244.5
|
Net income
1 |
73.17
|
160.6
|
81.64
|
161
|
181.8
|
202.9
|
Net margin
|
6.06%
|
8.9%
|
4.91%
|
8.04%
|
8.78%
|
10.14%
|
EPS
2 |
0.0909
|
0.1667
|
0.0848
|
0.1682
|
0.1905
|
0.2126
|
Free Cash Flow
1 |
-4.503
|
-210.1
|
39.35
|
179.5
|
228.5
|
-234.2
|
FCF margin
|
-0.37%
|
-11.64%
|
2.36%
|
8.96%
|
11.03%
|
-11.71%
|
FCF Conversion (EBITDA)
|
-
|
-
|
12.6%
|
50.33%
|
63.66%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
48.2%
|
111.49%
|
125.66%
|
-
|
Dividend per Share
2 |
0.0400
|
0.0900
|
0.0600
|
0.0900
|
-
|
0.0500
|
Announcement Date
|
4/19/18
|
4/19/19
|
4/27/20
|
4/26/21
|
4/28/22
|
4/25/23
|
Fiscal Period: December |
2022 S1
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
130.8
|
Net margin
|
-
|
EPS
2 |
0.1370
|
Dividend per Share
|
-
|
Announcement Date
|
8/25/22
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
246
|
439
|
430
|
235
|
422
|
Net Cash position
1 |
232
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.7688
x
|
1.404
x
|
1.204
x
|
0.6543
x
|
1.096
x
|
Free Cash Flow
1 |
-4.5
|
-210
|
39.4
|
180
|
229
|
-234
|
ROE (net income / shareholders' equity)
|
4.95%
|
9.15%
|
5.03%
|
8.14%
|
8.78%
|
9.15%
|
ROA (Net income/ Total Assets)
|
2.7%
|
3.81%
|
3.33%
|
3.85%
|
3.75%
|
4.07%
|
Assets
1 |
2,715
|
4,215
|
2,449
|
4,180
|
4,852
|
4,989
|
Book Value Per Share
2 |
1.980
|
2.060
|
2.050
|
2.150
|
2.280
|
2.500
|
Cash Flow per Share
2 |
0.9600
|
0.6200
|
0.3800
|
0.6600
|
0.6400
|
0.4700
|
Capex
1 |
172
|
311
|
103
|
93.9
|
91.2
|
190
|
Capex / Sales
|
14.2%
|
17.23%
|
6.2%
|
4.69%
|
4.4%
|
9.49%
|
Announcement Date
|
4/19/18
|
4/19/19
|
4/27/20
|
4/26/21
|
4/28/22
|
4/25/23
|
|
1st Jan change
|
Capi.
|
---|
| -16.89% | 793M | | +2.08% | 3.63B | | -17.29% | 2.23B | | -9.08% | 1.92B | | +2.07% | 1.88B | | -1.75% | 1.67B | | -2.30% | 1.32B | | +7.87% | 1.17B | | -20.13% | 1.03B | | -3.74% | 993M |
Pesticide
|